Gestational diabetes triggers postpartum cardiac hypertrophy via activation of calcineurin/NFAT signaling

Nirmal Verma, Sarah Srodulski, Sathya Velmurugan, Amanda Hoskins, Vivek K. Pandey, Florin Despa, Sanda Despa

Research output: Contribution to journalArticlepeer-review

Abstract

Population-based studies identified an association between a prior pregnancy complicated by gestational diabetes mellitus (GDM) and cardiac hypertrophy and dysfunction later in life. It is however unclear whether GDM initiates this phenotype and what are the underlying mechanisms. We addressed these questions by using female rats that express human amylin (HIP rats) as a GDM model and their wild-type (WT) littermates as the normal pregnancy model. Pregnant and two months postpartum HIP females had increased left-ventricular mass and wall thickness compared to non-pregnant HIP females, which indicates the presence of concentric hypertrophy. These parameters were unchanged in WT females during both pregnancy and postpartum periods. Hypertrophic Ca2+-dependent calcineurin/NFAT signaling was stimulated two months after giving birth in HIP females but not in the WT. In contrast, the CaMKII/HDAC hypertrophy pathway was active immediately after giving birth and returned to the baseline by two months postpartum in both WT and HIP females. Myocytes from two months postpartum HIP females exhibited slower Ca2+ transient relaxation and higher diastolic Ca2+ levels, which may explain calcineurin activation. No such effects occurred in the WT. These results suggest that a GDM-complicated pregnancy accelerates the development of pathological cardiac remodeling likely through activation of calcineurin/NFAT signaling.

Original languageEnglish
Article number20926
JournalScientific Reports
Volume11
Issue number1
DOIs
StatePublished - Dec 2021

Bibliographical note

Funding Information:
This work was supported by the National Institutes of Health (Grant Numbers HL148443 and HL135000 to S.D., HL118474 to F.D.), American Heart Association (Grant Number 19TPA34850094 to S.D.) and the University of Kentucky Research Alliance for Reduction of Diabetes Associated Microvascular Dysfunction (ADAM). Current affiliation for SS: ParaTechs Corporation, Lexington, KY, 40505, USA.

Publisher Copyright:
© 2021, The Author(s).

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'Gestational diabetes triggers postpartum cardiac hypertrophy via activation of calcineurin/NFAT signaling'. Together they form a unique fingerprint.

Cite this